Browsed by
Tag: Cancer

Liver cancer treatment costly for Medicare patients, UT Southwestern study finds: Newsroom
Liver cancer treatment costly for Medicare patients, UT Southwestern study finds: Newsroom

Liver cancer treatment costly for Medicare patients, UT Southwestern study finds: Newsroom

Liver cancer is forecast to be the No. 3 induce of cancer deaths by 2040, said Dr. Amit Singal and his colleagues. Cancer procedure fees in the United States are expected to approach $250 billion by 2030. (Image credit history: Getty Photos) DALLAS – Jan. 30, 2023 – Hepatocellular carcinoma (HCC), the most widespread style of liver most cancers, can area a substantial economic burden on patients, in accordance to an examination led by a researcher at UT Southwestern Health-related Heart. Amit…

Read More Read More

Peloton’s Leanne Hainsby Reveals Breast Cancer Symptom and Diagnosis at 35
Peloton’s Leanne Hainsby Reveals Breast Cancer Symptom and Diagnosis at 35

Peloton’s Leanne Hainsby Reveals Breast Cancer Symptom and Diagnosis at 35

Peloton instructor Leanne Hainsby just shared some challenging news with her followers. In an psychological Instagram article, the 35-year-outdated exposed that she’s been battling breast cancer for the earlier 6 months. “Two days just before my ideal friend’s funeral, I discovered a lump in my breast,” she wrote. “That actually is a sentence I Under no circumstances imagined crafting.” Hainsby posted a photo of herself going through procedure and gave her followers a glimpse into her cancer journey. “Following numerous…

Read More Read More

Opinion: Women don’t have to die from cervical cancer
Opinion: Women don’t have to die from cervical cancer

Opinion: Women don’t have to die from cervical cancer

Editor’s Observe: Dr. Eloise Chapman-Davis is director of gynecologic oncology at NewYork-Presbyterian/Weill Cornell Clinical Heart and Weill Cornell Drugs. Dr. Denise Howard is chief of obstetrics and gynecology at NewYork-Presbyterian Brooklyn Methodist Clinic and a vice chair of obstetrics and gynecology at Weill Cornell Medicine. The sights expressed in this commentary are their very own. Examine extra viewpoint on CNN. CNN  —  As doctors who focus in women’s reproductive health and fitness, we are on the front lines of a…

Read More Read More

Riverdance legend Michael Flatley shares health update with hospital release picture after ‘aggressive cancer’ diagnosis
Riverdance legend Michael Flatley shares health update with hospital release picture after ‘aggressive cancer’ diagnosis

Riverdance legend Michael Flatley shares health update with hospital release picture after ‘aggressive cancer’ diagnosis

MICHAEL Flatley has certain enthusiasts that he’s on the mend immediately after therapy for most cancers. The superhoofer posted a picture to say he experienced been introduced from the healthcare facility. 6 Michael shared a overall health update with his followers 6 The dance icon has certain admirers that he’s on the mend soon after treatment for most cancers 6 Michael was lately identified with most cancers It experienced not been recognized where by the Chicago-born dancer was staying treated…

Read More Read More

Cancer centre funding boost to widen UK trials of ‘treatments of the future’ | Cancer
Cancer centre funding boost to widen UK trials of ‘treatments of the future’ | Cancer

Cancer centre funding boost to widen UK trials of ‘treatments of the future’ | Cancer

Cancer clients will have greater obtain to medical trials of personalised therapies right after a funding raise for specialised healthcare centres made to make new therapies available as before long as feasible. Doctors and experts at 29 experimental cancer drugs centres (ECMCs) in the United kingdom are to receive £43m in contemporary support above the future five many years to demo new therapies for kids and grown ups. These consist of medication that persuade the immune method to assault tumours…

Read More Read More

Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

On-monitor to initiate Phase 2 demo in Q1 2023 NEW YORK, Dec. 29, 2022 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a affected individual-focused biopharmaceutical company, these days announced that the U.S. Food stuff and Drug Administration (Food and drug administration) has accepted an Investigational New Drug (IND) software for the firm’s HT-001 therapeutic for the treatment for rash and pores and skin issues associated with epidermal growth factor receptor (EGFR) inhibitor treatment. EGFR inhibitors are critical therapeutic agents for the remedy…

Read More Read More